Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Dawson James Downgrades ProPhase Labs to Neutral

Dawson James analyst Jason Kolbert downgrades ProPhase Labs (NASDAQ:PRPH) from Buy to Neutral.

byBenzinga Newsdesk

October 13, 2021

1 minute read

Dawson James analyst Jason Kolbert downgrades ProPhase Labs (NASDAQ:PRPH) from Buy to Neutral.

Evercore ISI Group Downgrades Health Catalyst to In-Line, Raises Price Target to $11

By Benzinga Newsdesk

Today, 9:54 PM

Evercore ISI Group analyst Elizabeth Anderson downgrades Health Catalyst (NASDAQ:HCAT) from Outperform to In-Line and raises the price target from $10 to $11.

HCAT

RBC Capital Maintains Sector Perform on EastGroup Properties, Raises Price Target to $207

By Benzinga Newsdesk

Today, 9:54 PM

RBC Capital analyst Michael Carroll maintains EastGroup Properties (NYSE:EGP) with a Sector Perform and raises the price target from $177 to $207.

EGP

Analyst Ratings

Expert Ratings for JOANN

By Benzinga Insights

Today, 9:54 PM

JOANN (NASDAQ:JOAN) has observed the following analyst ratings within the last quarter:

JOAN

News

Delta CEO Ed Bastian Says Travel Sector Of The Economy Is Going To Be Very Strong Through The December Quarter And Into The New Year

By Benzinga Newsdesk

Today, 9:54 PM

- Reuters

DAL

Dawson James Downgrades ProPhase Labs to Neutral

Related Posts

Evercore ISI Group Downgrades Health Catalyst to In-Line, Raises Price Target to $11

RBC Capital Maintains Sector Perform on EastGroup Properties, Raises Price Target to $207

Expert Ratings for JOANN

Delta CEO Ed Bastian Says Travel Sector Of The Economy Is Going To Be Very Strong Through The December Quarter And Into The New Year